Price Alert

Delcath Systems Inc. (DCTH)

NASDAQ: DCTH · Real-Time Price · USD

10.48

-0.63 (-5.67%)

At close: Aug 14, 2025, 3:59 PM

10.79

2.96%

After-hours: Aug 14, 2025, 07:12 PM EDT

-5.67% (1D)

Bid	9.9
Market Cap	366.6M
Revenue (ttm)	44.44M
Net Income (ttm)	2.23M
EPS (ttm)	0.09
PE Ratio (ttm)	116.44
Forward PE	17.85
Analyst	Strong Buy

Ask	11.2
Volume	567,975
Avg. Volume (20D)	772,390
Open	10.96
Previous Close	11.11
Day's Range	10.42 - 11.00
52-Week Range	7.36 - 18.23
Beta	0.82

About DCTH

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol DCTH

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for DCTH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Delcath Systems has released their quartely earnings on Aug 6, 2025:

Revenue of $24.16M exceeds estimates by $1.51M, with 211.05% YoY growth.

EPS of 0.07 exceeds estimates by 0.05, with 114.58% YoY growth.

Next Earnings Release

Delcath Systems Inc. is scheduled to release its earnings on Nov 7, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

+1.14%

Delcath Systems shares are trading higher after th... Unlock content with Pro Subscription

2 months ago

-6.32%

DCTH stock has given up its prior gain. Delcath Systems shares were trading higher after the company issued FY25 guidance and provided business updates.

News

1 week ago · seekingalpha.com

Delcath Systems, Inc. (DCTH) Q2 2025 Earnings Call Transcript

Delcath Systems, Inc. (NASDAQ:DCTH ) Q2 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants David Hoffman - General Counsel, Corporate Secretary & Chief Compliance Officer Ger...

1 week ago · fool.com

Delcath (DCTH) Q2 Revenue Jumps 210%

1 week ago · zacks.com

Delcath Systems, Inc. (DCTH) Surpasses Q2 Earnings and Revenue Estimates

Delcath Systems, Inc. (DCTH) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.48 per share a year ago.

1 week ago · businesswire.com

Delcath Systems Reports Second Quarter 2025 Results and Business Highlights

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional oncology company focused on the treatment of primary and metastatic liver cancer...

2 weeks ago · businesswire.com

Delcath Systems to Participate at the Canaccord Genuity 45th Annual Growth Conference

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced tha...

3 weeks ago · businesswire.com

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of t...

3 weeks ago · businesswire.com

Delcath Systems to Host Second Quarter 2025 Earnings Call

4 weeks ago · zacks.com

Is the Options Market Predicting a Spike in Delcath Systems Stock?

Investors need to pay close attention to DCTH stock based on the movements in the options market lately.

2 months ago · seekingalpha.com

Delcath Systems: Growing Fast, But Business Model Is Fragile

Delcath's HEPZATO shows rapid sales growth and high pricing, but its efficacy is only moderately better than alternatives and not curative. The addressable market is small, treatment is complex, and f...

2 months ago · zacks.com

Delcath Systems, Inc. (DCTH) Is Up 0.62% in One Week: What You Should Know

Does Delcath Systems, Inc. (DCTH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Load More News